tast disrupt
havent gotten much pushback worri around integr risk frankli
perplex market reaction quarter result anyth
perform bore mani concern sure posit news
stand-alone revenu surpris upsid organ vs even
well short expect compani lower full-year sale outlook
busi ebit forecast busi move lower sinc deal
first announc acknowledg realiti chang
commod currenc environ continu cautiou around potenti
busi disrupt frutarom come togeth
given histori serial tough nail frutarom true organ
potenti perform doesnt paint encourag pictur per
commentari call frutarom sale low-single-digit
math impli organ sale mid-single-digit rang ex-tim
issu link shift order pattern organ growth flat best
notabl differ versu mid-single-digit clip mani anticip though
compani take full-year outlook revenu growth think
assum sole matter fx headwind lower contribut rather
organ slow versu mid-high singl digit clip
regard lower contribut isnt factor wed
found unconvent start includ materi contribut
financi multi-year basi notabl though compani mention
cross-sel opportun time understand revenu
synergi part transact math share street yet
sens guidanc compound-annual-growth-rate revenu growth next three
year cross-sel play bigger role forecast perhap
quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
underweight acknowledg
abl navig challeng oper
environ perhap better wed initi
expect howev concern around
integr frut dilut associ
transact
upsid case base multipl
upsid case ep estim assum
trade slight discount peer
peer trade current premium
downsid case base multipl
downsid case ep estim
yesterday report ep compar consensu
stock weve quick recogn strateg merit
iff/frutarom combin remain measur forward look view
compani given realiti integr magnitud
tast disrupt
havent gotten much pushback worri around integr risk frankli
perplex market reaction quarter result anyth
perform bore mani concern sure posit news
stand-alone revenu surpris upsid organ vs even
short expect compani lower full-year sale outlook busi
ebit forecast busi move lower sinc deal first
announc acknowledg realiti chang commod
currenc environ continu cautiou around potenti busi
disrupt frutarom come togeth
given histori serial tough nail frutarom true organ
potenti perform doesnt paint encourag pictur per commentari
call frutarom sale low-single-digit math impli
organ sale mid-single-digit rang appreci cfo rich
oleari direct acknowledg busi disrupt aros deal close
process help pars factor drive top-lin soft name shift
custom order pattern commodity-ori busi sum
headwind mid-single-digit drag revenu growth would impli organ
growth exclud time issu flat best notabl differ versu
mid-single-digit clip mani anticip though compani take full-
year outlook revenu growth think assum sole matter fx
headwind lower contribut rather organ slow versu
mid-high singl digit clip
math organ sale growth ex-tim issu flat best notabl
differ versu mid-singl digit clip mani anticip
regard lower contribut isnt factor wed found
unconvent start includ materi contribut financi
 multi-year basi recal first announc would acquir
frut compani preliminari accretion/dilut math base ebitda number
well ahead consensu estim includ unannounc
 transact notabl though compani mention cross-sel
opportun time understand revenu synergi part
transact math share street august earn call said
havent put much revenu synergi plan yet sens
guidanc compound-annual-growth-rate revenu next three year cross-sel
play bigger role forecast perhap dial back key
question cours whether find frutarom project pipelin bit less
interest initi assum initi pro-forma model assum
revenu frut stand decreas
stem lower balanc lower organ growth
expect includ revenu synergi all-in model frut revenu
chang model model organ sale growth legaci
busi note mark acceler stack given greater price
flow fragranc busi work off-set commod inflat
currenc expect headwind all-in model net sale
quarter expect frutarom contribut sale quarter reflect
deal close date octob expect gross margin legaci bp
yoy note mark gradual recoveri cost inflat origin
anticip given increment inflat compani raw materi profil sinc last
updat fold dilut frutarom model gross margin bp
quarter model combin busi bp yoy sg
bp bring all-in estim oper margin bp
assumpt reflect cost synergi expect begin earnest
term line item forecast interest expens
reflect full-quart impact higher financ cost share count million
share lower tax rate versu prior estim provid off-set all-in
model ep lower prior estim take ep
estim reflect compani decis exclud amort
expens full-year benefit off-set aforement dilut
higher weight averag share count
look ahead expect organ sale growth within stand-alone
busi acceler reflect increment price fragranc busi
expect frutarom revenu reflect organ growth bp
contribut unannounc bp revenu synergi off-set slightli
bp neg currenc expect gross margin bp reflect
dilut stand-alone frutarom off-set posit price synergi
flattish sg bp yoy inclus synergi captur model ebit
margin bp full-year bring all-in estim ep
reflect benefit compani decis exclud amort lower tax
rate full-year off-set dilut higher weight averag share count
lauren lieberman herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
